Cell Migration in Tuberculosis Infection
结核感染中的细胞迁移
基本信息
- 批准号:7391536
- 负责人:
- 金额:$ 38.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-08-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAnti-Inflammatory AgentsAnti-inflammatoryAntimycobacterial AgentsAreaAttentionBacillus (bacterium)BiologicalCXCR3 geneCell Adhesion MoleculesCellsCessation of lifeChronic PhaseCollectionComplexDiseaseEquilibriumFundingGoalsGranulomaGranulomatousHandHumanImmuneImmune responseImmune systemImmunityImmunocompetentImmunologic FactorsImmunologicsIn VitroIndividualInfectionInfection ControlInfection preventionInflammatoryInvestigationKineticsKnock-outLifeLigandsLiteratureLungModelingMusMycobacterium tuberculosisNumbersOrganismPathogenesisPathologicPathologyPersonsPhagocytesPhasePlayRiskRoleSignal TransductionSiteStructureTestingTimeTuberculosisTumor Necrosis Factor-alphaTumor Necrosis Factorsbasecell motilitycell typechemokinechemokine receptordisease transmissionfollow-uphuman TNF proteinimmunopathologyin vivomacrophagemigrationmycobacterialnovelpathogenprogramsresponsetransmission processvigilance
项目摘要
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis is a remarkably successful human pathogen, and has coexisted with humans for thousands of years. Although only -10% of infected individuals develop active tuberculosis, the shear number of latently infected persons results in 8 million new cases of TB and 2 million deaths worldwide every year. The immune response to M. tuberculosis proceeds slowly but culminates in a granuloma. This collection of immune cells not only functions to focus the immune response on the area of infected macrophages, but also serves as an immunologic barrier to dissemination of the infection throughout the lungs. Interestingly, a proportion of M. tuberculosis bacilli can survive and persist in the granuloma, and this structure appears to greatly facilitate transmission of disease by causing pathology in the lungs. Thus, the granuloma is the intermediate goal for both the host and the pathogen. This makes identifying the "protective" and "pathologic" features of the immune response to M. tuberculosis complex and difficult. As a collaborative project for the past 14 years, we have studied the signals and factors that result in cell migration and granuloma formation in tuberculosis, with particular attention paid to tumor necrosis factor (TNF). TNF is a master regulator of the granulomatous response and of many aspects of the immune system. Humans treated with TNF neutralizing agents have a substantially increased risk of tuberculosis. We propose to follow up on our previous findings to study aspects of TNF and cell migration in the murine model of tuberculosis. Specifically, we will identify mechanisms the pro- and anti-inflammatory mechanisms related to TNF in M. tuberculosis infection (Aim 1), generate novel inducible knockout strains to determine which cell types are responsible for controlling the various phases of infection (Aim 2), and follow up on surprising findings that the chemokine receptor CXCR3 may impair the ability of the host to control M. tuberculosis infection (Aim 3). Our goal is a better understanding of the interplay between host and pathogen during infection, to identify strategies to eliminate persistent organisms.
描述(由申请人提供):结核分枝杆菌是一种非常成功的人类病原体,已经与人类共存了数千年。尽管只有-10%的受感染者发生活跃的结核病,但潜在感染者的剪切数量每年导致800万例新的结核病和200万例死亡。对结核分枝杆菌的免疫反应缓慢地进行,但最终在肉芽肿中达到顶点。这种免疫细胞的集合不仅功能将免疫反应集中在感染巨噬细胞的区域上,而且还充当了整个肺部感染传播感染的免疫障碍。有趣的是,结核分枝杆菌的比例可以在肉芽肿中存活并持续存在,这种结构似乎通过在肺部引起病理学而极大地促进了疾病的传播。因此,肉芽瘤是宿主和病原体的中间目标。这使得识别对结核分枝杆菌复合物和困难的免疫反应的“保护性”和“病理”特征。作为过去14年的协作项目,我们研究了导致结核病细胞迁移和肉芽肿的信号和因素,并特别注意肿瘤坏死因子(TNF)。 TNF是肉芽肿反应和免疫系统许多方面的主要调节剂。用TNF中和剂处理的人类患有结核病的风险大大增加。我们建议跟进我们以前的发现,以研究结核鼠模型中TNF和细胞迁移的方面。具体而言,我们将确定与结核分枝杆菌感染中与TNF相关的促和抗炎机制的机制(AIM 1),生成新型的诱导型敲除菌株,以确定哪些细胞类型负责控制感染的各种阶段(AIM 2),并跟进了令人惊讶的发现,即趋于趋化因子受体CXCR3可能会受到危险感染的IMM。我们的目标是更好地理解感染过程中宿主与病原体之间的相互作用,以确定消除持续生物的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John R. Chan其他文献
John R. Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John R. Chan', 18)}}的其他基金
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
9973940 - 财政年份:2020
- 资助金额:
$ 38.73万 - 项目类别:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
10685658 - 财政年份:2020
- 资助金额:
$ 38.73万 - 项目类别:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
10553212 - 财政年份:2020
- 资助金额:
$ 38.73万 - 项目类别:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
Rv2623-Rv1747 相互作用:结核分枝杆菌体内命运的调节
- 批准号:
10529446 - 财政年份:2020
- 资助金额:
$ 38.73万 - 项目类别:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
结核病中吲哚胺 2,3-双加氧酶的免疫调节
- 批准号:
9921293 - 财政年份:2018
- 资助金额:
$ 38.73万 - 项目类别:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
结核病中吲哚胺 2,3-双加氧酶的免疫调节
- 批准号:
10395488 - 财政年份:2018
- 资助金额:
$ 38.73万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Experiences of Discrimination, Dysbiosis, and Racial Disparities in Ovarian Cancer
卵巢癌中的歧视、生态失调和种族差异的经历
- 批准号:
10371537 - 财政年份:2023
- 资助金额:
$ 38.73万 - 项目类别:
Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions
青少年神经发生和中风后恢复的机制:确定与年龄相关的神经免疫相互作用的作用
- 批准号:
10637874 - 财政年份:2023
- 资助金额:
$ 38.73万 - 项目类别:
Circadian control of neuroinflammation after spinal cord injury
脊髓损伤后神经炎症的昼夜节律控制
- 批准号:
10639178 - 财政年份:2023
- 资助金额:
$ 38.73万 - 项目类别:
Prevention of intracellular infection in diabetic wounds by commensal Staphylococcus epidermidis
共生表皮葡萄球菌预防糖尿病伤口细胞内感染
- 批准号:
10679628 - 财政年份:2023
- 资助金额:
$ 38.73万 - 项目类别:
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 38.73万 - 项目类别: